| Product Code: ETC7633488 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Ireland continued to witness a steady increase in low molecular weight heparin import shipments, with top exporting countries being the USA, UK, Germany, Netherlands, and Mexico. Despite a moderate concentration level indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 stood at 4.67%, demonstrating a consistent uptrend. Notably, the growth rate spiked to 14.51% from 2023 to 2024, indicating a significant acceleration in import volumes for this vital healthcare product.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Low Molecular Weight Heparin Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Low Molecular Weight Heparin Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Low Molecular Weight Heparin Market - Industry Life Cycle |
3.4 Ireland Low Molecular Weight Heparin Market - Porter's Five Forces |
3.5 Ireland Low Molecular Weight Heparin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Ireland Low Molecular Weight Heparin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Low Molecular Weight Heparin Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Low Molecular Weight Heparin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about the benefits of low molecular weight heparin in preventing blood clotting |
4.2.3 Technological advancements in the production and formulation of low molecular weight heparin |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new low molecular weight heparin products in Ireland |
4.3.2 Pricing pressures and competition from generic versions of low molecular weight heparin |
5 Ireland Low Molecular Weight Heparin Market Trends |
6 Ireland Low Molecular Weight Heparin Market, By Types |
6.1 Ireland Low Molecular Weight Heparin Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Enoxaparin, 2021- 2031F |
6.1.4 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Dalteparin, 2021- 2031F |
6.1.5 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Tinzaparin, 2021- 2031F |
6.1.6 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.2 Ireland Low Molecular Weight Heparin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Deep Vein Thrombosis, 2021- 2031F |
6.2.3 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Acute coronary syndrome (ACS), 2021- 2031F |
6.2.4 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Pulmonary Embolism, 2021- 2031F |
6.3 Ireland Low Molecular Weight Heparin Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Ireland Low Molecular Weight Heparin Market Revenues & Volume, By Ambulatory Surgical, 2021- 2031F |
7 Ireland Low Molecular Weight Heparin Market Import-Export Trade Statistics |
7.1 Ireland Low Molecular Weight Heparin Market Export to Major Countries |
7.2 Ireland Low Molecular Weight Heparin Market Imports from Major Countries |
8 Ireland Low Molecular Weight Heparin Market Key Performance Indicators |
8.1 Number of new prescriptions for low molecular weight heparin |
8.2 Patient adherence rates to low molecular weight heparin therapy |
8.3 Number of clinical trials and research studies on low molecular weight heparin conducted in Ireland |
9 Ireland Low Molecular Weight Heparin Market - Opportunity Assessment |
9.1 Ireland Low Molecular Weight Heparin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Ireland Low Molecular Weight Heparin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Low Molecular Weight Heparin Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Low Molecular Weight Heparin Market - Competitive Landscape |
10.1 Ireland Low Molecular Weight Heparin Market Revenue Share, By Companies, 2024 |
10.2 Ireland Low Molecular Weight Heparin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |